A carregar...

Breast Tenderness and Breast Cancer Risk in the Estrogen plus Progestin and Estrogen-Alone Women’s Health Initiative Clinical Trials

BACKGROUND: The associations between breast tenderness during use of conjugated equine estrogen (CEE) therapy with or without medroxyprogesterone (MPA) therapy and subsequent breast cancer risk are unknown. METHODS: We analyzed data from the Women’s Health Initiative Estrogen plus Progestin (N = 16,...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Crandall, Carolyn J., Aragaki, Aaron K., Cauley, Jane A., McTiernan, Anne, Manson, JoAnn E., Anderson, Garnet, Chlebowski, Rowan T.
Formato: Artigo
Idioma:Inglês
Publicado em: 2011
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3697872/
https://ncbi.nlm.nih.gov/pubmed/22042371
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10549-011-1848-9
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!